Back to calendar
Syndax Pharmaceuticals, Inc. (SNDX) Earnings
SNDX reports earnings on Monday, November 2, 2026
earnings report
November 2, 2026 · After Market Close
Q3 2026
Est. EPS: $-0.49
Actual EPS: $-0.55
EPS surprise: -22.86%
Company overview
Market Cap$1.2B
PriceUSD 13.65
EPS (TTM)-2.52
52-week high25.59
52-week low12.79
SectorHealth Technology
IndustryBiotechnology
Employees298